Cancer and immunology Editorial overviewM. Moore · 1989

Cancer editorial overviewH. Koprowski; G. Rovera · 1990

Cancer: Editorial overviewJames P Allison · 2000

Cancer: Editorial overviewEllen Vitetta · 1999

Editorial overview: Viruses and cancerDamania, Blossom; Lieberman, Paul · Current Opinion in Virology · 2015

Gynecologic cancer Editorial overviewOzols, Robert F. · Current Opinion in Oncology · 1989

Gynecologic cancer Editorial overviewOzols, Robert F. · Current Opinion in Oncology · 1991

Development of distamycin-related DNA binding anticancer drugsMarchini, Sergio; Broggini, Massimo; Sessa, Cristiana; D’Incalci, Maurizio · Expert Opinion on Investigational Drugs · 2001

Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing miceTina Colombo; Massimo Broggini; Laura Torti; Eugenio Erba; Maurizio D'Incalci · 1982

Central side effects of pentamethylmelamine: Biochemical and behavioural studiesCarlo Perego; Massimo Broggini; Silvio Garattini; Maurizio D'Incalci; Guido Achilli; Maria Lipartiti; Franca Ponzio · 1984

In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinomaMassimo Broggini; Eugenio Erba; Luciano Morasca; Carmel Horgan; Maurizio D'Incalci · 1986

Horseradish peroxidase/hydrogen peroxide-catalyzed oxidation of VP16-213. Identification of a new metaboliteMassimo Broggini; Cosmo Rossi; Emilio Benfenati; Maurizio D'Incalci; Roberto Fanelli; Pierluigi Gariboldi · 1985

Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elementsBroggini, Massimo; Ponti, Mauro; Ottolenghi, Sergio; D'Incalci, Maurizio; Mongelli, Nicola; Mantovani, Roberto · Nucleic Acids Research · 1989

Studies of the mode of action of antitumour triazenes and triazines—III. Metabolism studies on hexamethylmelamineCharles Brindley; Andreas Gescher; Simon P. Langdon; Massimo Broggini; Tina Colombo; Maurizio D'incalci · 1982